Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients
نویسندگان
چکیده
منابع مشابه
P-56: Effect of Metformin and Orlistat on OvulatoryStatus in Obese PCOS Patients
Background: Polycystic Ovary Syndrome (PCOS) is the commonest cause of anovulatory infertility. Treatment modes available are numerous. The use of anti-obesity medications such as orlistat or insulin sensitizing agents such as metformin is sometimes indicated in these patients. We aimed to compare the effect of metformin vs orlistat on the hormone, lipid profile &ovulation status in obese PCOS ...
متن کاملComparison of the effects of sibutramine and orlistat on obese, poorly-controlled type 2 diabetic patients.
BACKGROUND We assessed and directly compared weight loss effects of sibutramine and orlistat treatment in a group of obese, poorly-controlled type 2 diabetic patients. METHODS This study recruited 34 diabetic subjects [glycohemoglobin (HbA1c) > 8%] with a body mass index of at least 27 kg/m2. A 36-week, three-phase, prospective, randomized, cross-over comparative study was conducted. In phase...
متن کاملEconomic evaluation of treatment with orlistat in Italian obese patients.
UNLABELLED The XENDOS study showed that behavioural and pharmacological therapy can decrease the risk of metabolic disorders in obese patients. METHODS A probabilistic Bayesian Markov model simulating the outcomes of orlistat treatment on the obese Italian population has been developed with the WinBUGS software. The model integrates an algorithm to estimate cardiovascular risk based on Framin...
متن کاملEffect of orlistat alone or in combination with Garcinia cambogia on visceral adiposity index in obese patients
AIM The objective of this study was to estimate the effect of orlistat alone and in combination with Garcinia cambogia on visceral adiposity index (VAI) in obese patients. PATIENTS AND METHODS A total of 99 obese male patients were recruited with aged range between 37 and 46 years. They were randomized into three equal groups, first group treated with orlistat 120 mg/day, second group treated...
متن کاملOBSERVATIONS Diabetic Ketoacidosis Associated With Orlistat Treatment
O rlistat is a drug frequently prescribed as an adjuvant in weight control therapy (1–2). Orlistat inhibits gastric and pancreatic lipases in the lumen of the gastrointestinal tract to decrease the systemic absorption of dietary fat (1,2). In clinical trials, steatorrhoea and other gastrointestinal disorders are the most frequently reported side effects (3). Other reported adverse effects inclu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Endocrine Journal
سال: 2010
ISSN: 0918-8959,1348-4540
DOI: 10.1507/endocrj.k10e-049